University of Minnesota Masonic Children's Hospital
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT03241082
The overall objective of the proposal is to evaluate the ability of ultrasound to predict and routinely (weekly) monitor changes in the body composition of healthy preterm infants in the neonatal intensive care unit (NICU) in response to nutritional intake. The investigators hypothesize that ultrasound is an accurate method to routinely monitor the quality of weight gain and assess the adequacy of nutritional provision for premature infants in the neonatal intensive care unit.
The investigators will address the hypothesis in the following Specific Aims:
Specific Aim 1: Validate ultrasound as a method to measure whole body fat mass and fat free mass in healthy, premature infants. Body composition will be assessed using ultrasound measurements and the validated method of air displacement plethysmography (ADP). Stable isotope dilution techniques will be used in a subset of our population as a secondary source of validation.
Specific Aim 2: Determine whether ultrasound measurements can detect clinically relevant (weekly) changes in body composition in healthy premature infants. Ultrasound will be used to obtain serial (weekly) measurements of muscle and adipose tissue thickness (triceps, abdomen, quadriceps) until discharge in healthy, premature infants.
This study is active but is not currently recruiting participants.
Notify Me25 week–34 week
All sexes
Observational
Minneapolis, Minnesota, 55455, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-Require medical support preventing ADP measurements
validation of portable ultrasound to measure body composition
Time frame: Up to 6 weeks
Measurement of whole body fat mass and fat-free mass via air displacement plethysmography and stable isotope dilution.
University of Minnesota
Other
Use of Bedside Ultrasound to Assess Neonatal Body Composition in the Neonatal Intensive Care Unit
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927833
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial DetailsNCT07100353
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Taoyuan, Taiwan
View Trial DetailsNCT03345069
Brain Damage, Chronic, Brain Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT03906435
Behavior, Behavioral Symptoms
Dallas, Texas, United States
View Trial Details